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Role of stromal-derived factor-1 in the
hematopoietic-supporting activity of human
mesenchymal stem cells
Human bone marrow (BM) mesenchymal stem
cells (MSC) have the capacity to give rise to
adipocytes, osteocytes and chondrocytes (1). Re-
cent findings indicate that they may have a broader
differentiation potential and develop into myo-
blasts, endothelial cells as well as non-mesodermal
cells such as hepatocytes or neural cells (2). Ex vivo-
expanded MSC can be reproducibly generated from
adult BM and maintained in undifferentiated state
for extended periods of time. Interestingly, undif-
ferentiated MSC support the proliferation and
differentiation of hematopoietic stem/progenitor
cells (HSPC) in vitro (3). These findings may be
translated into the possible use of autologous MSC
in ex vivo expansion of HSPC. However, mecha-
nisms underlying the hematopoietic-supporting
ability of MSC are not fully understood.
Stromal-derived factor-1 (SDF-1) is a critical
factor in the regulation of hematopoiesis. Acting on
its receptor CXCR4, SDF-1 is essential for normal
hematopoietic development through its action on
fetal BM seeding by HSPC (4). In postnatal
hematopoiesis, SDF-1 mediates selective BM hom-
ing and retention of HSPC transplanted by intra-
venous infusion (5). In addition, SDF-1 may also
stimulate ex vivo survival and proliferation of
purified HSPC (6, 7). SDF-1 is secreted by BM
immature cells located in the endosteal region as
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Abstract: Mesenchymal stem cells (MSC) have the ability to support
and maintain hematopoiesis in vitro. However, mechanisms implicated
in this support are not fully characterized. In the present study, the role
of stromal-derived factor-1 (SDF-1)/CXCR4 axis in the interactions
between MSC and hematopoietic stem/progenitor cells (HSPC) was
studied. Human bone marrow MSC were plated as feeder layers in
Dexter-type long-term cultures (LTC) with human cord blood CD34+
HSPC. Cultures were supplemented weekly with neutralizing antibodies
against CXCR4 or SDF-1 for 5 wk. LTC-initiating cell (IC) activity was
strongly dependent on the SDF-1/CXCR4 axis, as both antibodies sig-
nificantly decreased secondary colony-forming cell production. To as-
sess the effect of SDF-1/CXCR4 axis on progenitor cell proliferation,
LTC-IC killing assays were carried out: in LTC of CD34+ cells in
contact with MSC, treatment with anti-CXCR4 antibody significantly
reduced the number of cycling progenitors. These results indicate that
the SDF-1/CXCR4 axis promotes HSPC proliferation in contact with
MSC. Interestingly, when HSPC were separated from MSC by a semi-
permeable membrane, LTC-IC activity became CXCR4 independent.
Multiplex analysis of MSC-conditioned medium revealed that in addi-
tion to SDF-1, MSC produced stimulatory and inhibitory factors, such
as interleukin (IL)-6, IL-11, granulocyte macrophage-colony stimulating
factor as well as monocyte-chemoattractant protein-1. Altogether, hu-
man MSC support hematopoiesis in Dexter-type cultures through the
activation of the SDF-1/CXCR4 axis. Our data further suggest that
SDF-1 stimulates retention of HSPC in MSC niches which expose them
to stimulatory and inhibitory factors in a paracrine manner.
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well as by BM endothelial cells (8). Interestingly,
SDF-1 is highly expressed by immature pre-osteo-
genic MSC and rapidly downregulated in MSC
cultured in osteo-inductive conditions (9). Alto-
gether, these findings suggest that SDF-1 may be a
critical factor involved in the stimulation of hema-
topoiesis by undifferentiated MSC.
In the present study, we investigated the contri-
bution of SDF-1/CXCR4 interactions in the hema-
topoietic-supporting ability of MSC in vitro.
Dexter-type long-term cultures (LTC) of human
cord blood (CB) CD34+ cells were established with
human MSC as feeder layers. Neutralization of
endogenously produced SDF-1 was achieved with
specific antibodies blocking SDF-1 or its receptor
CXCR4. The effect of SDF-1/CXCR4 inhibition on
the proliferative potential and cycling status of very
primitive HSPC was determined in 5-wk LTC
assays.
Materials and methods
Human hematopoietic and mesenchymal cells
Umbilical CB blood samples were collected asep-
tically following full-term vaginal delivery accord-
ing to the guidelines established by the ethical
committee of the University of Liège. A Ficoll-
Hypaque (Pharmacia Amersham, Uppsala, Swe-
den) gradient centrifugation was used to isolate
mononuclear low density cells. CD34+ cells were
purified using MACS CD34 isolation kit (Miltenyi
Biotech, Bergisch Gladbach, Germany) as per
manufacturer’s instructions. The immunomagnetic
separation was performed twice to achieve maximal
purity of the CD34+ fraction, which was always
>97%.
Cryopreserved human BM MSC were obtained
from Cambrex (Verviers, Belgium) and subcultured
in mesenchymal stem cell growth medium (Camb-
rex). Cells were pretested for differentiation capa-
city into osteogenic, chondrogenic and adipogenic
lineages. As for antigenic phenotype, cells were
pretested for absence of CD45 and CD34, and
presence of CD105, CD29 and CD44, which was
confirmed in our laboratory prior to the experi-
ments described above.
Long-term cultures
Dexter type LTC of CB CD34+ cells were per-
formed over feeder layers of MSC. MSC were
plated at the concentration of 15 · 103 cells/cm2.
Within a week, CD34+ cells were seeded in 24-well
plates at 1000 cells/well at 33C in a 100% humid-
ified atmosphere and 5% CO2 in 1.5 mL LTC
medium. LTC medium consisted of aMEM (Camb-
rex) supplemented with 12.5% horse serum (Stem
Cell Technologies, Meylan, France), 12.5% fetal
bovine serum (FBS; Invitrogen, Paisley, Scotland),
0.2 mm i-inositol (Sigma, Bornem, Belgium),
10)4 m 2-mercaptoethanol (Invitrogen) and 2 mm
l-glutamine (Cambrex). Cultures were maintained
by weekly half-medium changes. After 5 wk, the
medium was gently aspirated and cells were har-
vested by trypsinization before being transferred
into semisolid medium as described below to
measure secondary colony-forming cell (CFC)
production. In some experiments, HSC and MSC
co-cultures were supplemented weekly with 1/100
dilution of anti-CXCR4 (BD Biosciences, Erem-
bodegem, Belgium), anti-SDF-1 (R&D, Abingdon,
UK) or CD3 (BD Biosciences) neutralizing anti-
bodies to assess the role of SDF-1/CXCR4 axis on
progenitor cell output. No azide – low endotoxin
antibody formulations were used in these assays.
Non-contact LTC were set up by plating 500
CD34+ cells in the upper chamber of 12-mm
diameter 0.4-lm pore TranswellsTM (Costar, Cam-
bridge, MA, USA). The lower chamber was seeded
with 15 · 103 MSC/cm2 in 2 mL LTC medium.
Medium feeding and secondary CFC assays were
done as described above.
Colony-forming cell (CFC) assays
Hematopoietic progenitors were assayed in semi-
solid media composed of 1.3% methylcellulose
(Stem Cell Technologies), 30% FBS (Cambrex),
100 ng/mL rh stem cell factor (SCF), 10 ng/mL rh
interleukin-3 (IL-3), 10 ng/mL rh interleukin-6 (IL-
6), 5 ng/mL rh granulocyte macrophage-colony
stimulating factor (GM-CSF; all from Peprotech,
Boechout, Belgium) and 2 U/mL erythropoietin
(EPO, Amgen, Brussels, Belgium) suspended in
Iscove’s modified Dulbecco’s medium. After 2 wk,
numbers of burst-forming unit-erythroid (BFU-E),
colony forming unit-granulocyte macrophage
(CFU-GM) and mixed colonies (CFU-mix) were
scored with an inverted microscope with ·40
magnification.
LTC killing assays
At the end of 5-wk LTCs, cells were trypsinized and
half of the collected cells was treated with 2 mg/mL
of hydroxycarbamide (HC) for 1 h at 37C while
the other half was saved as control. Cells were
washed and transferred in semisolid medium for
progenitor assays. The proportion of cycling LTC-
initiating cells (IC) was calculated from the number
of secondary CFC killed by HC treatment com-
pared to the number of secondary CFC produced
by control cells (10).
SDF-1 in hematopoietic support of MSC
489
Flow cytometric determination of CXCR4 and SDF-1 expression
Expression of SDF-1 in CD34+ cells and MSC was
determined by intracellular labeling. Cells were
washed in phosphate-buffered saline (PBS) without
bovine serum albumin (BSA) and suspended in
1 mL of 0.4% paraformaldehyde before adding
1 lL of Brefeldin A (GolgiPlug; BD Biosciences).
After a 30 min incubation at 4C, 1 mL of 0.2%
Triton X100 (Sigma) was added. Cells were incu-
bated for another 30 min at 4C before washing in
PBS 1% BSA. Once permeabilized, cells were
incubated with biotinylated anti-SDF-1 (R&D) or
isotype-matched control IgG (BD Biosciences) for
60 min at 4C and with streptavidin-allophycocy-
anin (Molecular Probes, Leiden, the Netherlands)
for another 60 min at 4C. For the determination
of surface expression of CXCR4, cells were washed
in PBS 1% BSA and incubated with PE–conjugated
anti-CXCR4 antibody or isotypic control IgG (BD)
for 20 min at 4C in the dark. Cells were washed in
PBS 1% BSA and fixed in PBS 1% paraformalde-
hyde. Flow cytometric data were acquired on a
FACSort flow cytometer (BD Biosciences) and
analyzed by the cellquest software (BD Bio-
sciences).
Multiplex analysis of MSC-conditioned medium
Quantification of IL-3, IL-6, IL-11, leukemia-
inhibitory factor (LIF), GM-CSF, G-CSF, mono-
cyte chemoattractant protein (MCP)-1, SDF-1,
macrophage inflammatory protein (MIP)-1a, inter-
feron (IFN)-c, transforming growth factor (TGF)-
b, intercellular adhesion molecule (ICAM)-1, vas-
cular cell adhesion molecule (VCAM)-1, E-selectin,
L-selectin and matrix metalloprotease (MMP)-9
was performed by multiplex enzyme-linked immu-
nosorbent assay (ELISA) as per manufacturer’s
instructions (SearchlightTM proteome array, Per-
bio, Erembodegem, Belgium). Briefly, 16 capture
antibodies were bound to each well of a microplate.
After addition of culture supernatants and removal
of unbound proteins, plates were incubated with
biotinylated detection antibodies, followed by
streptavidin-horseradish peroxydase (all reagents
supplied by Perbio). Chemiluminescent signals were
detected with a cooled CCD camera (Photometrics,
Zeiss, Brussels, Belgium).
Results
To assess the hematopoietic-supporting ability of
MSC, Dexter-type LTC of CB CD34+ cells were
established for 5 wk using MSC as feeder layers.
Secondary CFC production per 103 CD34+ cells
plated at LTC initiation was used as a measure of
primitive progenitor cell activity. In the presence of
MSC, progenitor output was 240.7 ± 51.3 secon-
dary CFC while no hematopoietic activity was
detected after LTC in the absence of MSC. To
determine the possible role of SDF-1/CXCR4 axis
in mediating MSC supporting ability, LTC were
supplemented weekly with neutralizing antibodies
against CXCR4 or SDF-1. Anti-CD3 was used as
control (Fig. 1A). Neutralization of CXCR4 de-
creased the output of secondary progenitors by
more than 50% compared to control cultures (n ¼
6; P ¼ 0.002). Neutralization of SDF-1 induced a
similar inhibitory effect (n ¼ 3; P ¼ 0.04).
We next analyzed the expression of CXCR4 by
MSC and CB CD34+ progenitor cells. Flow
cytometric analysis revealed the presence of
CXCR4 on the surface of the CD34+ cells while

































Fig. 1. Neutralization of stromal-derived factor-1 (SDF-1)
and CXCR4 in mesenchymal stem cell (MSC)-supported
human long-term cultures (LTC). LTC were treated with
neutralizing antibodies anti-SDF-1 or anti-CXCR4 for
5 wk. (A) Colony-forming cell (CFC) output per 1000
CD34+ cells plated at LTC initiation. (B) % cycling CFC at
the end of 5 wk LTCs was determined by killing assays.
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measured in MSC- and CD34+ cell-conditioned
medium by ELISA. Supernatant of MSC cultures
contained 726.3 ± 140.9 pg/mL SDF-1 (n ¼ 4)
whereas no SDF-1 was detected in medium condi-
tioned by CD34+ cells. As measures of secreted
SDF-1 may be underestimated by autocrine cell
consumption, intracellular production of SDF-1
(iSDF-1) was measured by flow cytometry after cell
permeabilization and treatment with Brefeldin A.
While SDF-1 production was absent in CD34+
cells, the chemokine was readily detected in MSC
(Fig. 2). By combining functional and phenotypical
data it appears that SDF-1 is produced by MSC,
binds CXCR4 receptor on the surface of CD34+
cells and mediates important signals implicated in
maintaining hematopoietic activity in Dexter-type
LTC cultures.
It has been previously reported that SDF-1
stimulates the proliferative status of purified hema-
topoietic progenitors in suspension cultures (6).
However, such effect of SDF-1 has not been
examined so far in cultures of hematopoietic
progenitors plated in contact with human MSC.
The cycling status of hematopoietic progenitors
was determined by killing assays: cells harvested
from LTC after 5 wk were treated with hydroxy-
carbamide to eliminate progenitors in S phase,
prior to transfer in secondary progenitor assays.
The proportion of cycling progenitors was calcula-
ted by comparison with untreated control cells
(Fig. 1B). In LTC supplemented with an irrelevant
antibody (anti-CD3), the proportion of cycling
progenitors was 31.0 ± 3.5% (n ¼ 3). In contrast,
in the presence of anti-CXCR4 neutralizing anti-
body, progenitor proliferation index decreased to
8.3 ± 3.3% (P ¼ 0.009). These data demonstrate
that CXCR4 stimulates the cell cycle activity of
hematopoietic progenitors cultured in contact with
human BM-derived MSC.
We next examined whether the stimulation of
hematopoietic activity by MSC through CXCR4-
mediated signals could be elicited by soluble factors
produced by MSC. To this end, we set up non-
contact LTC in which CD34+ cells were separated
from MSC feeder layers by a Transwell filter
(Fig. 3). In that fashion, neither neutralization of
CXCR4 (266.2 ± 27.6 CFC/1000 CD34+ cells)
nor blocking of SDF-1 (239.2 ± 13.8) significantly
affected secondary CFC production compared to
control cultures (302 ± 13.8; P > 0.05). Thus,
MSC may support hematopoiesis in the absence
of direct contact with CD34+ cells but this
Fig. 2. CXCR4 and stromal-derived
factor-1 (SDF-1) expression in CD34+
cells and mesenchymal stem cells
(MSC). Membrane CXCR4 was
measured in MSC (A) and cord blood
(CB) CD34+ cells (B). Intracellular
SDF-1 was measured in MSC (C) and
CD34+ cells (D) after Brefeldin treat-
ment and cell permeabilization. Stain-
ing with control IgG is shown in dotted
lines.
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supporting activity does not involve the SDF-1/
CXCR4 axis.
Finally, to identify soluble factors potentially
involved in the maintenance of hematopoiesis in
non-contact cultures, we carried out a multiplex
analysis of 16 cytokines or adhesion molecules in
MSC-conditioned medium (Table 1). Various acti-
vating cytokines were actively produced by MSC
notably IL-6, IL-11 and GM-CSF. Among inhib-
itory factors IFN-c, TGF-b and MIP-1a were not
detected, while high concentrations of MCP1 were
secreted. Among adhesion molecules, both soluble
VCAM-1 and ICAM-1 were present in MSC-
conditioned medium, suggesting their active role
in mediating binding of CD34+ cells to MSC. MSC
secreted also MMP-9 which might be important for
the release and activation of membrane-bound
cytokines (11). Altogether, MSC produce many
factors which might be implicated in the mainten-
ance of hematopoietic activity even in the absence
of direct contact with progenitor cells.
Discussion
Although its primary role in hematopoiesis is to
regulate homing and retention of stem cells in the
bone marrow microenvironment (12), SDF-1 may
be implicated in other processes. The effect of
SDF-1 on the proliferative status of HSPC has
been studied previously but conflicting results
were reported. First, it was described that SDF-1
acts as a survival and mitogenic factor in
suspension cultures of purified CD34+ cells (6,
13). Our results are consistent with these studies
since neutralization of CXCR4 was associated
with impaired progenitor cell cycling and de-
creased CFC output by LTC-IC. In other reports,
SDF-1 was found to inhibit HSPC cycling in
Dexter-type cultures. This discrepancy with the
present study may be due to methodological
differences. Cashman et al. studied the effect of a
single addition of neutralizing anti-SDF-1 in
LTCs that had been initiated 1 wk previously,
while we studied progenitor cycling and produc-
tion in LTCs after a 5-wk treatment with
blocking antibodies. Extension of LTC duration
enabled us to determine the effect of SDF-1/
CXCR4 neutralization on more primitive hema-
topoietic progenitor cells, in which CXCR4 sign-
aling is reportedly higher in comparison to more
mature ones (12). Also, feeder cells used by
Cashman et al. consisted of mouse marrow
fibroblasts engineered to secrete SCF, IL3 and
G-CSF, which may produce a largely different set
of cytokines and chemokines, compared to
human MSC (14).
The stimulatory effect of SDF-1 on hematopoi-
etic progenitor cell growth in LTC established on
MSC layers may be direct or indirect. We observed
that CXCR4-mediated hematopoietic-supporting
ability of MSC requires contact with CD34+ cells.
In non-contact LTC, MSC are still able to maintain
hematopoietic progenitor activity but in a CXCR4
independent fashion. This may indicate that the
role of SDF-1/CXCR4 axis is indirect, by stimula-
ting retention of hematopoietic progenitors in













Fig. 3. Neutralization of stromal-derived factor-1 (SDF-1)
and CXCR4 in non-contact mesenchymal stem cell (MSC)-
supported long-term cultures (LTC). CD34+ cells were
separated from MSC by a Transwell filter. Colony-forming
cell (CFC) output per 1000 CD34+ cells plated at LTC
initiation was measured.
Table 1. Multiplex enzyme-linked immunosorbent assay (ELISA) analysis of


















Concentrations of indicated proteins were measured in MSC-conditioned medium
after 3 d at confluence (n ¼ 4). *P < 0.10 compared to medium only.
ND, not detected; IL, interleukin; LIF, leukemia-inhibitory factor; G-CSF, granulocyte-
colony stimulating factor; GM-CSF, granulocyte macrophage-colony stimulating
factor; IFN, interferon; TGF, transforming growth factor; MCP, monocyte chemoat-
tractant protein; SDF, stromal-derived factor; MIP, macrophage inflammatory pro-
tein; ICAM, intercellular adhesion molecule; VCAM, vascular cell adhesion
molecule; MMP, matrix metalloprotease.
Van Overstraeten-Schlögel et al.
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them to adhesion molecule-mediated signals in a
paracrine fashion.
While we did not detect CXCR4 receptor on the
cell surface of MSC, it remains possible that
CXCR4 is indeed expressed in MSC but internal-
ized in response to autocrine binding of SDF-1
(15). It was recently reported that SDF-1 promotes
growth and survival of bone marrow stromal cells
in an autocrine manner (9). Neutralization of
CXCR4 or SDF-1 could then possibly affect the
viability of MSC feeder layers in LTC and conse-
quently their hematopoietic-supporting ability.
However, in non-contact cultures, hematopoietic
activity was maintained during CXCR4 neutraliza-
tion, which argues against a direct effect of SDF-1
on MSC function.
In conclusion, we have demonstrated that SDF-
1/CXCR4 is critical in mediating the maintenance
of the hematopoietic niche provided by cultured
undifferentiated MSC. This finding could have
important implications for designing ex vivo expan-
sion procedures in valuable clinical applications.
We suggest that careful monitoring of SDF-1
secretion by cultured MSC might be used as a
predictive assay for the efficiency of MSC lines to
support growth of HSPC in contact cultures.
Further investigation of the hematopoietic support
provided by subpopulations of undifferentiated and
committed MSC may help define other important
regulators of hematopoiesis.
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